Zosano Pharma Corporation (NASDAQ: ZSAN) shares are 7.89% up in the year-to-date (YTD) period and have moved -2.96% or -$0.05 lower in the latest trading session. However, stock’s trailing 12-month performance remains nearly +304.94% lower. Comparatively, the stock is -16.33% down YTD and 67.35% over the trailing 3-month period. If we look at the shorter duration, its week performance is -9.89% and 97.61% over the month.
On March 24, 2017, Piper Jaffray recommended the ZSAN stock is a Overweight, while earlier, Maxim Group had Initiated the stock as a Buy on April 17, 2019.
The stock currently trades at $1.64. The forecasts give the Zosano Pharma Corporation stock a price target range of $7.00 on the higher side while at least one analyst think the stock could plunge to a low of $2.00. The two limits represent an upside potential of 76.57% or 18.0%.
Analysts estimate the earnings to decrease 0.00% in the current quarter to -$0.12, up from the -$0.55 reported in the same quarter a year ago. Analysts also offered guidance for the next financial quarter, with their average projected EPS at between -$0.12 and -$0.08. Wall Street estimates earnings per share to be at an average of -$0.2 for the next year.
Insider Transactions Summary
According to SEC data, total insider shares purchases at the company stands at 11 over the last 12 months, while SEC filings reveal that there have been 0 insider sales over the same period. Insiders have purchases 937,155 shares while those sold by company executives and officers stand at 0. The last 3 months have seen insiders trade a total of 247,500 and 0 in purchases and sales respectively.
Galiano Gold Inc. (AMEX:GAU), on the other hand, is trading around $1.59 with a market cap of $363.55M and analyst research firms have a negative stance on its shares.
Let us briefly look at the Galiano Gold Inc. (GAU) financials, with a focus on its operating details as indicated in its earnings report for the last quarter.
Company balance sheet and cash flow
GAU’s operating expenses over the recent quarter were at $2.7 million. This represented a 122.45% of the company’s total revenues which amounted -$12.01 million. With this in place, we can see that the company’s diluted EPS inclined $0.07 on the year-over-year period, growing to $0.03 as given in the last earnings report.
The cash flow from operating activities totaled -$1.86 million, significantly higher than the -$3.62 million reported in the year-ago quarter. The company’s free cash flow for the quarter was -$1.89 million.
Insiders own 3.60% of the company shares, while shares held by institutions stand at 63.00% with a share float percentage of 222.42M. Investors are also buoyed by the number of investors in a company, with Galiano Gold Inc. having a total of 60 institutions that hold shares in the company.